An Observational Study on the Association Between Surrogates of Visceral Adiposity and Albuminuria in Type 2 Diabetes
Clinical Diabetology · 2024
DOI: 10.5603/cd.100161 ↗At a glance
Journal article in Clinical Diabetology, 2024. Written by Ümmügülsüm Durak and 6 co-authors.
Topics: Diabetes mellitus
Abstract (original language)
OBJECTIVE: This study aimed to investigate the associations between albuminuria and visceral adiposity in patients with type 2 diabetes (T2D). MATERIALS AND METHODS: This single-center crosssectional study included patients with T2D. Anthropometric measurements, urine analyses, and fasting blood tests, were conducted. Patients diagnosed with hepatosteatosis within the past 3 months were invited to undergo transthoracic echocardiography to measure epicardial fat thickness (EFT). The clinical, laboratory, and imaging findings of patients with microalbuminuria ( > 30 mg/day) were compared with those of patients without microalbuminuria using chi-square tests and t-tests. RESULTS: The study included 702 patients with a mean age of 58.9±10.9 years and a male predominance (57.8%). Microalbuminuria was present in 253 patients (36%). In the group with microalbuminuria, age, levels of glucose, triglycerides, HbA1c, FIB-4, and visceral adiposity index (VAI) scores were higher, while glomerular filtration rate (GFR), high-density lipoprotein (HDL) cholesterol levels, and the frequency of hypertension were lower compared to the patients without microalbuminuria (p < 0.05 for all). Out of 169 patients who underwent liver ultrasonography, hepatosteatosis was observed in 138 individuals (81.7%). Among the 59 patients who underwent echocardiography, an increased EFT was found in 25 (42.4%) patients. No significant differences were observed in EFT, hepatic steatosis presence, or stage between the microalbuminuria and non-microalbuminuria groups (p = 0.807, 0.834, and 0.351, respectively). CONCLUSIONS: While no associations were found between microalbuminuria and hepatosteatosis or EFT, patients with microalbuminuria showed higher VAI and FIB-4 scores. The findings underscore the potential of these scores in predicting microalbuminuria in patients with T2D.
Cite
APA
Durak, Ü., Keskinler, M. V., Feyizoglu, G. A., Durak, F., Torun, C., Karaaslan, T., & Oğuz, A. (2024). An Observational Study on the Association Between Surrogates of Visceral Adiposity and Albuminuria in Type 2 Diabetes. Clinical Diabetology. https://doi.org/10.5603/cd.100161
Vancouver
Durak Ü, Keskinler MV, Feyizoglu GA, Durak F, Torun C, Karaaslan T, et al. An Observational Study on the Association Between Surrogates of Visceral Adiposity and Albuminuria in Type 2 Diabetes. Clinical Diabetology. 2024. doi:10.5603/cd.100161
BibTeX
@article{Durak2024,
author = {Durak, Ümmügülsüm and Keskinler, Miraç Vural and Feyizoglu, Gunes Alkaya and Durak, Furkan and Torun, Cundullah and Karaaslan, Tahsin and Oğuz, Aytekin},
title = {An Observational Study on the Association Between Surrogates of Visceral Adiposity and Albuminuria in Type 2 Diabetes},
journal = {Clinical Diabetology},
year = {2024},
doi = {10.5603/cd.100161}
}
EUVIMED